Brief: Ma Yun's Long Position In Brii Biosciences At 7.58% - HKEx Filing
July 26 (Reuters) - Hong Kong Stock Exchange Filing Shows :
* MA YUN'S LONG POSITION IN BRII BIOSCIENCES LIMITED
2137.HK AT
7.58% ON JULY 13
Source text in English: https://bit.ly/2URRnxT
Further company coverage: 2137.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR